. This effect was not mimicked by application of the second messenger cGMP, in the water-soluble 8_bromo-cGMP form (Cudeiro et al. 1994a) . Such a mechanism is intriguing, given that at this location the sole source of NOS has been shown to be fibres arising from the parabrachial region of the brainstem, where NOS is colocalized with ACh (Bickford, G unl uk, Guido & Sherman, 1993) . In the cerebral cortex, however, NO production may arise from several possible sources: extrinsically from cholinergic fibres arising in the nucleus basalis of the forebrain (Bickford, G unl uk, Van Horn & Sherman, 1994) ; intrinsically from cells within the cortex which contain NOS (a subset of the non-spiny cortical neurons) (Bredt, Hwang & Snyder, 1990; Dawson, Bredt, Fotuhi, Hwang & Snyder, 1991; Kuchiiwa, Kuchiiwa, Mori & Nakagawa, 1994) ; or even from cortical blood vessels that are capable of NO production from the endothelial cells of the vessel walls ; for review see Iadecola, 1993) . Such a diversity of production sites suggests a more complex role in cortical visual processing than we have previously demonstrated in the thalamus. For example, recent evidence has shown that NO may be involved in the NMDAmediated release of noradrenaline and glutamate from rat cortical synaptosomes, suggesting that NO can have both direct actions and actions on modulatory processes (Montague, Guancayco, Winn, Marchase & Friedlander, 1994) . Of course, since the release of these compounds was specific to NMDA, the effects of NO on other excitatory amino acid receptor-mediated events remain untested. Nevertheless, there is to date little or no published evidence on the effect of NO, or the effect of blockade of NOS, on visual cortical cells. We have therefore examined such effects using microiontophoresis of a competitive inhibitor of NOS, N G _nitro-¬-arginine (¬_NOArg) and a NO donor, diethylamine-nitric oxide (DEA-NO). Specifically, we have sought to determine what role, if any, NO may have in the elaboration of cortical visual properties, as well as addressing the possibility of more global effects on cell excitability. Furthermore, given our previous findings on the mode of action of NO within the dLGN, where it selectively enhanced NMDA receptor-mediated activity, we have investigated whether such receptor specificity is involved in any cortical locus of action. A preliminary report of these data has been published (Cudeiro, Rivadulla, Rodriguez, Martinez-Conde &Acuña, 1995) .
METHODS
Experiments were carried out on nineteen adult cats in the weight range 1·8-2·5 kg. Animals were anaesthetized with halothane (0·1-5%) in nitrous oxide (70%) and oxygen (30%), and paralysed with gallamine triethiodide (40 mg initial dose, then 10 mg kg¢ h¢). EEG and ECG, expired COµ and temperature were monitored and maintained continuously, to ensure that anaesthetic levels were altered as appropriate to maintain an adequate state of light anaesthesia. Changes in parameters indicating a lightening of anaesthetic levels (e.g. changes in intersystolic interval, decreasing spindle frequency, rise in end-tidal COµ) were immediately counteracted by increasing halothane levels accordingly. Once a stable baseline level had been established any variation in the parameters monitored triggered an alarm system. Lignocaine (lidocaine) gel was applied to the ear bars of the stereotaxic frame and all wound margins were treated with subcutaneus injections of lignocaine and adrenaline. Further details of surgical procedures and maintenance can be found in Cudeiro & Sillito (1996) . Single units were recorded extracellularly from primary visual cortex (Horsley-Clarke coordinates: anteroposterior, −2 to −8 mm relative to interauricular line; mediolateral, +0·6 to +1·5 mm relative to mid-line) using seven barrelled glass micropipettes. Pipettes were filled with a combination of the following drugs: NaCl (3 Ò for extracellular recording); ¬_arginine (l-Arg; 10 mÒ, pH 6·0); N G -nitro-¬_arginine (l-NOArg; 10 mÒ, pH 6·0); Nmethyl-ª_aspartate (NMDA; 0·1 Ò, pH 8·0); á-amino-3-hydroxy-5-methylisoxasole-4-propionic acid (AMPA; 15 mÒ, pH 8); ACh (0·5 Ò, pH 4·0); diethylamine-nitric oxide (DEA-NO; 10 mÒ, pH 8·0); 8-bromo-cGMP (10 mÒ, pH 4·5); and Pontamine Sky Blue (PSB; 2% wÏv in 0·5 Ò sodium acetate solution for histological reconstruction applied at 20-40 ìA for 15-20 min). All drugs were purchased from Sigma and RBI. Pipette tips were broken back to diameters ranging from 3-10 ìm, and when not in use each drug barrel was subject to a constant retention current of 5-25 nA of appropriate polarity. Pipettes were inserted in a plane nearly perpendicular to the cortical surface and cells were recorded throughout the depth of the visual cortex. All neurons had visual fields centered within 10 deg of the area centralis. Single units were classified into simple and complex types by virtue of their responses to drifting light and dark edges (Henry, 1977) . Single-unit data were collected, and visual stimuli produced, under computer control (Visual Stimulation System, Cambridge Electronic Design, Cambridge, UK; for details see Sillito, Cudeiro & Murphy, 1993) . Stimuli were viewed monocularly through the dominant eye for each cell under test. The eyes were treated with atropine methonitrate and phenylephrine hydrochloride, and protected with plastic contact lenses. They were brought to focus on a semi-opaque tangent screen at a distance of 0·57 m using supplementary lenses and 2 mm diameter artificial pupils. Our basic protocol was to establish control responses to a drifting bar stimulus, moving backwards and forwards through the receptive field, at the optimal orientation. Subsequently, this procedure was repeated in the presence of the compound or compounds of interest. We also examined the effects of the drugs on spontaneous activity, and in some cases during a complete set of orientations of the moving bar, in which presentation of stimuli of different orientations was randomized. Typically, responses were averaged over ten to twenty stimulus presentations and were assessed from the accumulated count in the binned peristimulus time histograms (PSTHs), using separate epochs for baseline and visual responses. A change in firing was considered significant when P < 0·05 (Wilcoxon signed-rank test). Where error bars are shown these are ±1 s.e.m. To examine the nature of the action of NOS inhibitors on excitatory responses evoked by exogenously applied NMDA, AMPA or ACh, we used pulsatile iontophoretic application of the excitant before and during continuous application of ¬_NOArg (alone or in combination with ¬_Arg). The effect of iontophoretic ejection of 8_bromo-cGMP on visually driven activity was also tested. The magnitude of the drug iontophoretic application current was selected on the basis of initial qualitative observations. Effects were generally seen within the range 60-120 nA and no ejection current above this range was used. At the end of each experiment, the animals were killed by anaesthetic overdose and the locations of the recording sites were determined in Nissl-stained sections from PSB deposits made at the sites of interest. All procedures were carried out in accordance with Spanish National Guidelines, the International Council for Laboratory Animal Science and the European Union (86Ï809).
RESULTS
This report is based on data obtained from a sample of seventy-seven cells located throughout the depth of the primary visual cortex. On the basis of their responses to ¬_NOArg application we have divided this population into two groups, with clear responses to this compound in one group, and no effect in the other. However, no other visual response property clearly belonged to one group or the other. There was therefore no relationship between the actions of the compounds applied that modulated the nitric oxide system and the receptive field type, layer and degree of direction or orientation selectivity. Twenty-nine out of seventy-seven cells were affected by iontophoretic application of ¬_NOArg. As shown in Fig. 1 , the major effect of ¬_NOArg was suppressive (25Ï29). Here the responses of a non-directionally selective complex cell located in layers II-III (Fig. 1A) were markedly reduced (•60%) by continuous application of ¬_NOArg (Fig. 1B) , along with a suppression of background firing (see below). Effects were manifest within 3-4 min of application and had offset times in the range 6-10 min. Responses to both directions of stimulus motion were equally depressed. A shows the control responses to an optimally oriented bar of light moved backwards and forwards across the receptive field (here and in subsequent figures shown as an inset above the PSTHs). In B these responses were repeated during constant application of ¬_NOArg, and in C with both ¬_NOArg and ¬_Arg. Finally in D the test was repeated in the presence of ¬_Arg alone. In all cases where responses to ¬_Arg alone were compared with its effect on the ¬_NOArg effect, the same application current was used. Each PSTH is the mean of 15 trials, and bin width is 100 ms.
However, co-application of ¬_Arg completely reversed this ¬_NOArg-induced inhibition (Fig. 1C) . Application of ¬_Arg alone (Fig. 1D ), even at current levels exceeding those required to block or reverse the ¬_NOArg effect (data not shown), did not increase response levels above the control levels shown in Fig. 1A . In cells showing measurable spontaneous activity (14Ï25), this activity was also reduced during drug application, as illustrated in Fig. 2 . Here, the spontaneous activity of a simple cell in layer V is shown to be reduced by some 84%. In terms of visual responses, the effect of ¬-NOArg application was rapid, reaching peak effectiveness within a few minutes (Fig. 2B) . Again coapplication of the substrate for NOS, ¬_Arg, reversed the inhibitory effects of ¬_NOArg, but without measurably increasing spontaneous activity (Fig. 2C) . A second example of the inhibitory effect of ¬_NOArg application on visual responses is illustrated in Fig. 3 , where a simple cell in layer IV is shown. In this case we have illustrated ( Fig. 3A) a full control orientation tuning curve, with data points taken at 30 deg of visual angle intervals around 360 deg. This clearly highly orientation-and direction-selective cell, with little or no spontaneous activity, was heavily suppressed by application of ¬_NOArg (Fig. 3A , dashed line) with responses at all orientations and directions being affected. The responses to the optimal orientation are shown in detail in the PSTHs on the right (Fig. 3C) . Once again co-application of ¬_Arg prevented the effect of the NOS inhibitor (Fig. 3B ). This suppression of visual response and decreased spontaneous activity due to application of ¬_NOArg and the reversal of these effects by ¬_Arg co_application was common to all twenty-five cells. On average, in this group visual responses were reduced by 62 ± 4 % (means ± s.e.m., P < 0·001), and spontaneous activity by 56 ± 9 % (P < 0·001). In eleven cells the effect of the NO donor DEA-NO was also tested. As typified by the example in suppression induced by ¬_NOArg illustrated in Fig. 4D . All three cells showed such enhanced responses (mean, 84 ± 19 %) and, where present, spontaneous activity was also elevated. Response selectivity, for example, direction specificity, was unaffected when the response magnitude was maintained within subsaturation levels. In a subpopulation of ten cells, application of ¬_NOArg was inhibitory, as above, in three. In these three, application of the soluble analogue of cGMP, 8-bromo-cGMP, induced excitation. This is illustrated in Fig. 5 . Once again ¬_Arg alone was unable to elevate firing rates above control levels, while 8-bromo-cGMP clearly did so (mean, 106 ± 37 %) (Fig. 5D) . With regard to the pharmacological specificity of these effects, Fig. 6 shows a typical example taken from a subpopulation of six (out of 15) cells tested with application of each of the excitatory amino acids NMDA and AMPA. This figure shows clearly that the very potent inhibitory effect of ¬_NOArg is not selective between these two amino acids, reducing the response to each to near zero, and this effect was seen in all six cells, differing only quantitatively across the population. Again, the inhibitory effect was reversed by co-application of ¬_Arg (bottom PSTHs in Fig. 6) . In ten cells we tested the action of ¬_NOArg on the effectiveness of the non-amino acid excitant, ACh. In five of these cells, responses were heavily suppressed (in each of these five cells, visual responses were also affected, while in the remaining five neither visual nor ACh-mediated effects were altered), and this effect was reversed by concurrent application of ¬_Arg. This is illustrated by the PSTHs in Fig. 7A , with effects on visual responses shows in Fig. 7B . The histogram in Fig. 7C summarizes the effectiveness of NOS inhibition for the population of five cells. It is again striking that the ¬_NOArg-induced suppression was effectively blocked by ¬_Arg, which itself did not elevate activity. As mentioned above, in twenty-five out of twenty-nine cells affected by ¬-NOArg, visual responses were suppressed. However, in the remaining four (2 complex cells and 2 simple cells), the effect of ¬_NOArg was exactly the opposite -it induced a significant increase in the magnitude of the visual responses in each of these cells (58 ± 13 %). In the PSTHs from a simple cell in layer VI. A, control visual responses; B, depression during ¬_NOArg application; C, recovery; D, effect of 8-bromo-cGMP application; E, recovery; F, ¬_Arg application alone; and G, ¬_NOArg and ¬_Arg together. Each PSTH is the mean of 10 trials, and bin width is 100 ms. example in Fig. 8B , the visual responses during ¬_NOArg application are greatly enhanced compared with control values (Fig. 8A ) yet, as shown in Fig. 8E , responses during the combined application of both ¬_NOArg and ¬_Arg are equal to control values. In two of the five cells (out of a total of eleven) affected by DEA-NO application (see above), responses were reduced by some 43%, again showing an effect opposite to that of the larger population of cells affected by ¬_NOArg. Although few in number, these cells were extremely striking in the difference in their responses to these drugs, a difference that was clearly reproducible and that remained unchanged for as long as the recordings of these cells could be maintained. These cells are also exemplified by the cell illustrated in Fig. 8F , where DEA-NO application resulted in a clear suppression of the visual responses. In summary, Fig. 9 illustrates the laminar distribution of the cells affected and unaffected by ¬_NOArg as outlined above, broken down by cell type (see Fig. 9 legend) . We could find no significant correlation between cell type or lamina and the effectiveness of ¬_NOArg.
DISCUSSION
Based both on our previous work and that of other groups (Cudeiro et al. 1994a (Cudeiro et al. ,b, 1995 Kara & Friedlander, 1995) , we are confident that our iontophoretic application of Actions of the nitric oxide system in cat area 17 J. Physiol. 504.2 473 Figure 6 . Non-specific reduction of excitatory amino acid responses during NOS inhibition ¬_NOArg produces effective local inhibition of the enzyme NOS, thereby preventing release of NO, and we believe that the activity we see does not rely on other transmitter substances or pathways in the cortex, but represents the action of a tightly bound, slowly dissociating competitive antagonist at the ¬_Arg site of NOS (Furfine, Harmon, Paith & Garvey, 1993; Klatt, Schmidt, Brunner & Mayer, 1994) . By far the most potent effect of NOS inhibition we have seen is a depression of activity, both visually elicited and spontaneous. This effect is typical of our previous findings in the dLGN, where all cells encountered, of all cell types, showed just such a suppression during NOS inhibition. However, it is interesting to note that the majority of our population of seventy-seven cortical cells, some forty-eight, were completely unaffected by inhibition of NOS, and, moreover, unresponsive to the application of NO via the donor DEA-NO. It has previously been suggested that locally produced NO (such as that produced by DEA-NO) may affect cells within a volume of tissue in the order of 200 ìm in diameter (Wood & Garthwaite, 1994) . Thus cells without apparent responses to the application of ¬_NOArg would seem to lack the biochemical machinery necessary to respond to NO manipulating agents, rather than simply being outside of the 'reach' of the applied compounds. Indeed, cells both responsive and unresponsive to these compounds were found in the same electrode penetrations and there was no obvious grouping of the two cell types within individual tracks. This suggests a degree of 'parcellation' of cortical cells along an as yet undefined axis, but it is interesting in this context to note that cat cortex has recently been shown to contain cytochrome oxidase blobs (Murphy, Jones & Van Sluyters, Figure 7 . NOS inhibition depresses excitatory responses to exogenously applied ACh A, PSTHs showing control ACh responses, the effects of ¬_NOArg and recovery (bin width, 100 ms). B shows, in the same cell, the similar effects of ¬_NOArg application on visual responses. Each PSTH is the average of 10 trials, and bin width is 1 s. C, histogram summarizing the magnitude of the ¬_NOArg suppression of ACh-induced excitatory responses, and its reversal by co-application of ¬_Arg (alone without effect). The error bars indicate ± 1 s.e.m. 1995), the feature which first began the parcellation of primate cortex into regions more complex than orientation and ocular dominance columns (Wong-Riley, 1979; Horton & Hubel, 1981) . In primate layer VI, the distribution of NADPH, a marker for neuronal NOS, is closely aligned with that of cytochrome oxidase, showing a similar laminar and spatial distribution (Sandell, 1988) , and it is therefore possible that a larger and more detailed sampling of cells in a study such as ours may reveal an anatomical correlation of responsiveness to NO-modulating compounds and a cortical biochemical marker. While it is known that the input from the basal forebrain to the cerebral cortex utilizes ACh as a primary neurotransmitter (Bickford et al. 1994) , less is known about the nature of the cortical postsynaptic recipient structures. It has been suggested that the forebrain selectively influences target inhibitory interneurones in the cortex (Beaulieu & Somogyi, 1991) and such intracortical inhibitory influences have been proposed to 'sharpen' visual receptive field properties (Sillito, 1975 (Sillito, , 1977 Eysel, Worgotter & Pape, 1987; Ramoa, Paradiso & Freeman, 1988) . Indeed, the cholinerigic influence itself, mediated mainly by cholinergic muscarinic receptors, is known to enhance visual responsivity and modulate receptive field properties (Sillito & Kemp, 1983; Murphy & Sillito, 1991) . We therefore propose that an added NO-mediated influence may extend this direct influence to the neighbouring cells within a selected cortical region by diffusion and activation of NOmediated excitation, as we have demonstrated at the singleunit level above. In the cortex the mode of action of NO is clearly different to our findings in the thalamus in a number of ways. Firstly, in the visual thalamus (LGN and perigeniculate nucleus), all cells encountered were affected by NOS blockade (Cudeiro et al. 1994a (Cudeiro et al. ,b, 1996 , while in the cortex only some 38% were affected. Furthermore, our NOS blockade in the cortex depressed equally the NMDA receptor-mediated excitation and that induced by the non-NMDA-mediated AMPA receptors and ACh receptors in those cells affected by ¬_NOArg, while in the thalamus, cells were affected by NOS blockade by a mechanism selectively acting via NMDA receptor activation (Cudeiro et al. 1994a (Cudeiro et al. ,b, 1996 . The reduction in efficacy of these excitants during NOS blockade was lifted when ¬_Arg was co-applied both in the cortex and in the thalamus, and this was also the case for visual responses and spontaneous activity. This is in contrast to the findings of Montague et al. (1994) who suggested, from observations on rat cortical synaptosomes, that one action of NO was to augment glutamate or noradrenaline release, presumably from neighbouring synapses, as a result of NMDA receptor activation. Such a specific presynaptic mode of action seems unlikely to account for the straightforward reduction in NMDA-, AMPA-and ACh-mediated visual and spontaneous activity we have seen here in vivo. Indeed our findings with 8-bromo-cGMP suggest a simple modulation of the cGMP secondary messenger system, again in contrast to our findings in the thalamus. Such an action on cGMP has been widely reported in the literature (for reviews see Garthwaite, 1991; Moncada et al. 1991; Schuman & Madison, 1994; Zhang & Snyder, 1995) . We therefore suggest that for this population of cortical cells, during normal functioning, NO acts to enhance excitability in a global way, perhaps dealing with statedependent changes in excitability, a role already ascribed to the ascending cholinergic fibres arising from the basal forebrain (Buzs aki, Bickford, Ponomareff, Thal, Mandel & Gage, 1988; Bickford et al. 1994) . This seems to follow logically from the presence of NOS in these fibres, co_localized with ACh (Bickford et al. 1994) . The ability of co_applied ¬_Arg to reverse the effects of NOS blockade, while alone producing no excitation, mimics the effects we have reported in the dLGN (Cudeiro et al. 1994a (Cudeiro et al. ,b, 1996 . From these observations we suggest that in this situation, available NOS is a rate-limiting step such that increased levels of ¬_Arg above those which can be immediately processed by the enzyme are without effect. We further speculate that the Ca¥-dependent nature of this enzyme and its location in synaptic terminals suggests that available enzyme levels may fluctuate with the spiking activity of such terminals, 'following' the activation of the forebrain input to the cortex. The proportion of cells which were not responsive to manipulation of the NO system may of course be an underestimate in that, although it has been postulated that NO may diffuse over large distances to act on remote sites (Garthwaite, 1991; Wood & Garthwaite, 1994) , many cells in the visual cortex have dendritic arbours many times greater than the NO diffusion range (Martin & Whitteridge, 1984; Wood & Garthwaite, 1994) . As a consequence, an effect of NO on remote dendrites remains possible, and cannot at this stage be discounted. Whether or not such an effect exists does not, however, detract from the hypothesis that, under the conditions with which we have investigated the NO system, many cells seem to be unaffected. It should be remembered that there are multiple sources of NOS in cat cortex, including some spine-free cells, presumably GABAergic and inhibitory Dawson et al. 1991) . This may account for the smaller proportion of cells reported above in which the effects of ¬_NOArg and DEA-NO were the reverse of the majority of cells affected by ¬_NOArg -essentially suggesting a physiological inhibitory role for NO in these cells. However, it is true that many other hypotheses may account for this effect, and the extracellular recording technique does not allow identification of the morphologicalÏneurotransmitter cell type under study. Indeed, the variety of effects we have seen during iontophoretic drug application could result from trans-synaptic activation andÏor changes in the activity of local circuits. This is particularly relevant to applications of compounds that release NO, which is known to be highly diffusable (Wood & Garthwaite, 1994) and will be the subject of future studies. While changes in local perfusion might also account for some of the effects reported here, we believe this to be unlikely in the anaesthetized and paralysed preparation used here. In summary, we have demonstrated not only that a significant proportion, some 38%, of our sample of cortical cells is affected by the application of drugs capable of altering NO levels (showing reductions in visual responses when NO production is decreased), but also that there exists a small but significant proportion of affected cells (5%) whose visual responses are inhibited by NO, suggesting the existence of both an up-and down-regulation of cellular firing in separate subpopulations of cortical cells. Finally, our results suggest that, unlike in the visual thalamus, this regulation is carried out via the cGMP second messenger system.
